Navigation Links
Variations in antibiotic prescribing of acute rhinosinusitis in united states ambulatory settings
Date:5/9/2013

Alexandria, VA Antibiotics for acute rhinosinusitis (ARS) are prescribed frequently especially for younger adult patients and in primary care settingsdespite recent consensus guidelines that discourage antibiotic use in mild cases, according to a study in the May 2013 issue of OtolaryngologyHead and Neck Surgery.

"These variations should be of high relevance to policy makers, patients, and clinicians, with implications for payment for quality," the authors state.

The authors set out to identify national variations in using antibiotics to treat ARS. Study data were taken from outpatient visits between 2006 and 2009, from the National Ambulatory Medical Care Survey and National Hospital Ambulatory Care Survey. Sample data included outpatient visits of adults diagnosed with ARS who visited otolaryngologists or primary care physicians.

Citing prior research, the authors note that treating uncomplicated ARS with antibiotics has three fundamental limitations: Bacterial infections are thought to complicate a small proportion of cases; excessive antibiotic use is associated with consequences to individuals, including allergic reactions and medication side effects; and excessive antibiotic use is associated with consequences to society in the form of unnecessary costs and increasing bacterial resistance.

The data reflect several prescribing patterns for ARS patients. Physicians prescribed antibiotics in 82.3% of visits despite established clinical practice guidelines recommendations against the use of antibiotics for many ARS cases. Broad-spectrum types of medications are favored although other types may have fewer side effects, and prescription rates were inversely related to patient age.

Because the duration and severity of symptoms were not recorded, the authors caution that conclusions cannot be made about the validity of decisions to prescribe antibiotics.

In summary, the authors concluded that the findings highlight the importance of promoting clinical practice guidelines. "Future studies including an analysis of the cost burden of ARS, clarification of the prevalence of bacterial infection in ARS, and characterization of which ARS patients benefit from antibiotics are warranted."


'/>"/>

Contact: Mary Stewart
mstewart@entnet.org
703-535-3762
American Academy of Otolaryngology - Head and Neck Surgery
Source:Eurekalert

Related medicine news :

1. New technique catalogs lymphoma-linked genetic variations
2. Cell loss in the brain relates to variations in individual symptoms in Huntingtons disease
3. Researchers identify variations in four genes associated with an increased risk of colorectal cancer
4. Researchers identify variations in 4 genes associated with an increased risk of colorectal cancer
5. Study highlights variations in spinal component costs
6. 5 genetic variations increase risk of ovarian cancer
7. Genetic variations associated with susceptibility to bacteria linked to stomach disorders
8. Antibiotics Linked to Retinal Detachment Risk
9. Researchers find evidence of banned antibiotics in poultry products
10. Study Finds Antibiotics Best for Appendicitis
11. FDA Seeks to Limit Antibiotics in Animal Feed
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... 2016 , ... Quality metrics are proliferating in cancer care, and are derived ... eye of the beholder, according to experts who offered insights and commentary in the ... Care. For the full issue, click here . , For the American Society ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many ... been diagnosed with endometriosis. These women need a treatment plan to not only ... approach that can help for preservation of fertility and ultimately achieving a pregnancy. ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency ... named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June ... with. The article goes on to state that individuals are now more comfortable seeking ... common operations such as calf and cheek reduction. The Los Angeles area medical group, ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced ... attorneys chosen by their peers for this recognition are considered among the top 2 ... received special honors as members of this year’s Legal Elite Hall of Fame: ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... June 26, 2016 One of Australia,s ... the formation of a new biotechnology company, Noxopharm Limited [ABN 50 ... an IPO and to list on the ASX. Noxopharm ... ready to enter a Phase 1 clinical study later this year. ... address one of the biggest problems facing cancer patients - the ...
(Date:6/26/2016)... Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) announced ... Act of 1976, as amended ("HSR"), with respect to ... CPXX ) expired effective June 24, 2016, ... previously announced on May 31, 2016, Jazz Pharmaceuticals and ... Jazz Pharmaceuticals has commenced a tender offer for all ...
(Date:6/26/2016)... , June 27, 2016  VMS Rehab Systems, Inc. ... will take whatever measures required to build a strong ... which is currently listed on the OTC Markets-pink current ... Chairman and CEO, "We are seeing an anomaly in ... understand, not only by the Company, but shareholders and ...
Breaking Medicine Technology: